Introduction
The isoxazolyl series of sesnisynthetic penicillins, first synthesized and evaluated in these laboratories (Doyle et al., 1961; Hanson et al., 1965) , combines resistance to penicillinase with acid stability and activity against Gram-positive bacteria. The isoxazole penicillins in current clinical use-namely, oxacillin, cloxacillin, and dicloxacillin-are absorbed when given by mouth or by injection and show significant activity against penicillin-resistant staphylococci and other Gram-positive cocci. The therapeutic efficacy of the isoxazole penicillins in the treatment of staphylococcal and streptococcal infections is now well established.
Oxacillin, cloxacillin, and dicloxacillin have closely related chemical structures (Fig. 1) , and the antibacterial activities of these compounds are also similar, though oxacillin is somewhat less active than cloxacillin and dicloxacillin against penicillin-resistant staphylococci, and cloxacillin is rather less active than oxacillin and dicloxacillin against pneumococci (Knudsen et al., 1962; Bennett et al., 1965; Knott et al., 1965) .
The main differences among the isoxazole penicillins lie in the serum concentrations obtained after administration of the compounds and in the extent to which they are bound to serum protein.
Oxacillin, the first member of the series, gives rise to serum concentrations which are substantially lower than those obtained with cloxacillin both by mouth and by injection (Knudsen et al., 1962; Bunn and Milicich, 1964; Gravenkemper et al., 1964) , while dicloxacillin results in serum levels higher than those of cloxacillin when given by mouth (Bennett et al., 1965; Knott et al., 1965) . Dicloxacillin, however, is more highly bound to serum protein than is cloxacillin (Gloxhuber et al., 1965; Kunin, 1966) , and this factor may be held to detract from the superior levels of total antibiotic measured in the plasma (Gloxhuber et al., 1965; Rolinson, 1967; Medical Letter, 1968) .
In this present paper the properties of a further member of the isoxazole series is reported. This compound (3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl-penicillin has the generic name flucloxacillin (Floxapen) (Fig. 1) Table I , where it can be seen that flucloxacillin was active against the Gram-positive bacilli tested and against Gram-positive cocci, with the exception of Streptococcus faecalis. In general, the Gram-negative bacteria tested were relatively insensitive to flucloxacillin, the enterobacteriaceae requiring concentrations of 500 )ug./ml. or greater for inhibition.
Strains of Haemophilus influenzae, Bordetella pertussis, Pasteurella septica, and Brucella abortus were more susceptible, but were only inhibited by 5-0-12-5 ,ig/ml. In contrast, the gonococci and meningococci were sensitive to flucloxacillin, and were inhibited at a concentration of 0.1 tug./ml. Flucloxacillin was as active as cloxacillin against the test organisms and was generally five to ten times less active than benzylpenicillin against Gram-positive bacteria, with the exception of penicillinase-producing strains of staphylococci which were resistant to benzylpenicillin but sensitive to flucloxacillin.
Activity against Streptococci.-Flucloxacillin was inhibitory to /8-haemolytic streptococci at concentrations of 0.05-0.1 /ig./ml., and inhibited most of the pneumococci tested at concentrations of 0-1-0-25 ,tg./ml. (Table II) . Against these organisms flucloxacillin was as active as dicloxacillin and oxacillin, and was slightly more active than cloxacillin.
Activity against Staphylococci.-All four isoxazole penicillins showed a similar level of activity against penicillin-sensitive strains of staphylococci compared with 0.02 jug./ml. for benzylpenicillin (Table III ). In the case of the penicillin-resistant staphylococci most strains were inhibited by flucloxacillin at a concentration of 0-25-0-5 tLg./ml.; both flucloxacillin and dicloxacillin were marginally more active than cloxacillin, while oxacillin was the least active of the four isoxazole penicillins (Table III) . The stability of flucloxacillin to staphylococcal penicillinase compared with benzylpenicillin was further illustrated by determining the effect of altering the inoculum size on the relative activities of the penicillins against a penicillinase-producing strain of Staphylococcus aureus. In this test, benzylpenicillin was active against an inoculum of a 1/1,000 dilution of an overnight culture at a concentration of 0-25 ttg./ml., but against an undiluted culture the M.I.C. of benzylpenicillin was raised to 125 sg./ml. as a result of the penicillinase activity of the large inoculum. In contrast, the M.I.C. of flucloxacillin increased only twofold, from 0-25 to 0-5 ,ug./ml., under the same conditions.
Methicillin-resistant Staphylococci. -Naturally occurring strains of methicillinresistant staphylococci were also resistant to flucloxacillin as well as to cloxacillin and dicloxacillin (Table IV) . The resistance of these strains of staphylococci was not due to inactivation of the penicillin in question but to an intrinsic resistance. Such strains comprised mixed populations of cells of which only a minority was resistant while the majority was of normal sensitivity (Sutherland and Rolinson, 1964) . As a result of this heterogeneity a small inoculum appeared sensitive to the isoxazole penicillins, whereas a large inoculum appeared resistant. pH and Antibacterial Activity of was not greatly influenced by the pH of the medium, the penicillin being generally two to four times more active at pH 5-8 than at pH 7.2 or above. Bactericidal Activity.-In viable-count experiments both flucloxacillin and cloxacillin showed a similar degree of bactericidal activity against a penicillin-resistant strain of Staph. aureus, and concentrations only slightly greater than the M.I.C. resulted in a substantial reduction in the viable count during the first few hours (Fig. 2) . Effect of Serum on Antibacterial Activity.-Flucloxacilhin was 10 to 20-fold less active in 95% human serum than in nutrient broth, and a similar reduction in activity was also seen with cloxacillin and dicloxacillin. Thus the minimum bactericidal concentrations of these penicillins against two penicillinase-producing strains of Staph. aureus increased from 0.15 Ag./ml. in nutrient broth to 1.5-30 ,ug./ml. in human serum.
Binding of Flucloxacillin to Serum Proteins
The extent of binding of flucloxacillin and the other isoxazole penicillins to the proteins of human serum was measured by an ultrafiltration technique 
Sensitivity Disc Tests
Flucloxacillin sensitivity discs (5 pug.) produced inhibition zones in tests with penicillin-sensitive and penicillinaseproducing strains of Staph. aureus which were of the same order as those obtained with 5 pg. cloxacillin sensitivity discs. Naturally occurring strains of Staph. aureus, resistant to methicillin and to the isoxazole penicillins, often appeared to be sensitive to flucloxacillin discs, as with cloxacillin discs, though resistant colonies were sometimes observed within the inhibition zones when a large inoculum of cells was examined after overnight incubation at 370 C., and were common after incubation for 48 hours at 37°C. Dilute inocula almost invariably appeared sensitive when tested at 370C., as is the case for methicillin and cloxacillin (Sutherland and Rolinson, 1964) . Resistance to flucloxacillin was generally readily demonstrated when sensitivity tests were incubated at 30GC. (Annear, 1968) or involved the use of 5% NaCl agar (Barber, 1964; Sutherland, 1964) , as is the case with other penicillinase-stable penicillins.
Absorption and Excretion in Human Volunteers
Assay in Serum and Urine
The concentrations of flucloxacillin and other isoxazole penicillins in serum and urine were measured by standard cup-plate microbiological assay with Sarcina lutea N.C.T.C. 8340 as assay organism (Knudsen et al., 1962) . For the assay of serum specimens, standard solutions of flucloxacillin, cloxacillin, or dicloxacillin were prepared in pooled human serum to give a range of 0-5-50 pug./ml.; for urine specimens the standard solutions were prepared in M/20 phosphate buffer, pH 7-0, over a range of 0.25-20 ,ug./ml. Oxacillin was more active than the other penicillins against Sarcina lutea N.C.T.C. 8340, and was diluted in serum to give a range of 0-1-10 ,ug./ml. or in buffer from 0-05 to 5 [ig./ml. The plates were incubated overnight at 30°C., the inhibition zone diameters were measured, and the concentrations of the test specimens were derived from the standard line constructed from the standard solution.
Oral Administration
The penicillins were given in gelatin capsules as a single dose of 250 or 500 mg. to healthy fasting volunteer subjects.
Blood specimens were taken at 2, 1, 2, 3, 4, or 6 hours after administration of the dose, and urine was collected over the 0 to 6-hour period. Levels of total antibiotic were measured by microbiological assay, and the serum concentrations of free, unbound antibiotic were calculated from these total levels and from the values for the extent of binding of the isoxazole penicillins in human serum.
Data in Table VI represent the total and free serum levels obtained in numerous studies with fasting subjects given single oral doses of flucloxacillin, dicloxacillin, cloxacillin, or oxacillin. It will be seen that the total serum levels of oxacillin were substantially lower than those of cloxacillin, and likewise the free levels of oxacillin were less than those of cloxacillin. With dicloxacillin, a 250-mg. dose produced total serum levels comparable to those attained with the 500-mg. dose of cloxacillin. Dicloxacillin, however, is bound to serum protein to a significantly greater extent than cloxacillin, and consequently when this factor is taken into account the peak free levels of dicloxacillin were only about half those of cloxacillin. In the case of flucloxacillin, the total levels obtained with a 250-mg. dose were similar to those obtained with 250 mg. of dicloxacillin; but because flucloxacillin is bound to serum protein to a lesser degree than dicloxacillin the free serum levels of flpcloxacillin were considerably higher than those of dicloxacillin. The total levels of flucloxacillin after administration of a 250-mg. dose were almost equal to those obtained with 500 mg. of cloxacillin, and as the extent of binding of both penicillins is very similar, the unbound levels of flucloxacillin were only slightly lower than those of cloxacillin.
The mean values for flucloxacillin and cloxacillin obtained from three separate cross-over studies involving 43 healthy volunteers are shown in Fig. 3 . A single dose of 500 mg. was given in capsule form to the fasting subjects. It will be seen that at all times the serum levels of total antibiotic were considerably higher in the case of flucloxacillin than with clox- acillin. Levels of free flucloxacillin were also significantly higher than those of cloxacillin, since the extent of binding of these two compounds is similar. Similarly, data in Fig. 4 show the mean values for flucloxacillin and dicloxacillin obtained in two separate cross-over studies involving 32 subjects in the fasting state. In these studies a single dose of 250 mg. was given by mouth in capsule form. It will be seen that the serum levels of total antibiotic were similar for the two penicillins. As a result of the difference in serum binding, however, free levels of flucloxacillin were substantially higher than those of dicloxacillin. At the peak levels this difference was about twofold.
In these studies the absorption of the isoxazole penicillins showed considerable variation between one volunteer and another, and there was also considerable variation in the time at which peak blood levels were reached, though such variation is not apparent from the mean values as shown in Figs. 3 and 4. For example, in the cross-over studies with flucloxacillin and cloxacillin, at a dose of 500 mg. the peak levels of total antibiotic for the 43 subjects involved ranged from 3.4 to 26-5 jig./ml. in the case of flucloxacillin and from 1.5 to 30.0 pg./ml. with cloxacillin. Mean peak levels, irrespective of the time the peak was reached, were 14.7 ;ig./mL for flucloxacillin and 9.6 pg./ml. for cloxacillin, and as a result of a similar degree of serum binding the peak levels of unbound flucloxacillin were also significantly higher than those of cloxacillin. In the cross-over studies with flucloxacillin and dicloxacillin, at a dose of 250 mg., a wide range of peak values (from 3-0 to 26-0 jig./ml. with both penicillins) was again seen among the subjects involved. Mean peak total levels of flucloxacillin and dicloxacillin were similar (11-0 pig./ml.), but as a result of the difference in protein binding the mean peak levels of free flucloxacillin were considerably higher than those of dicloxacillin.
Urinary Excretion
In the cross-over study with flucloxacillin and cloxacillin at 500 mg. (Fig. 2) , 50.5% and 39-5% of the doses respectively were recovered in the urine collected over 0-6 hours. In the study with flucloxacillin and dicloxacillin at 250 mg. (Fig. 4) the recovery was 55% and 59% respectively over the same period.
Effect of Food on Absorption
Flucloxacillin was given at a 250-mg. or 500-mg. dose to volunteer subjects one hour after they had eaten a standard breakfast. Absorption of flucloxacillin was delayed and the peak serum concentrations were about half those obtained in fasting subjects (Table VII) reported for cloxacillin and oxacillin (Knudsen et al., 1962; Gravenkemper et al., 1964) .
Intramuscular Administration
Total and free serum levels are shown in Fig. 5 for cloxacillin, dicloxacillin, and flucloxacillin administered as single intramuscular injections of 250 mg. to healthy volunteers. The total levels of flucloxacillin were slightly higher than those of dicloxacillin, which in turn were higher than those of cloxacillin. Taking the extent of binding into consideration it will be seen that the free levels of flucloxacillin were appreciably higher than those of cloxacillin or dicloxacillin.
Data for oxacillin, cloxacillin, and flucloxacillin after intramuscular injection of a single 500-mg. dose to volunteers are shown in Fig. 6 . Total and free levels of the three compounds were similar with regard to the peak values, but the levels of flucloxacillin were considerably more prolonged than those of oxacillin and slightly more prolonged than with cloxacillin.
Discussion
Our results show that flucloxacillin was generally similar to oxacillin, cloxacillin, and dicloxacillin, in terms of spectrum and level of activity against Gram-positive bacteria. Thus Flucloxacillin was well absorbed in people after administration by both oral and intramuscular routes. When given by mouth flucloxacillin gave rise to total serum levels equivalent to those obtained with dicloxacillin, and superior to those of cloxacillin and oxacillin. Moreover, when the extent of serum binding of these penicillins was considered the free levels of flucloxacillin were superior to those of dicloxacillin as well as those of cloxacillin and oxacillin. The relationship of the total serum levels for a given oral dose of oxacillin, cloxacillin, dicloxacillin, and flucloxacillin might be expressed approximately as 1:2:4:4, respectively, but the levels of unbound penicillins would be 1:2:2:4. Thus the superior absorption of dicloxacillin compared with cloxacillin is counterbalanced by the higher serum binding of the former (Kunin, 1966; Medical Letter, 1968) whereas the higher total levels of MLDICBRmLJICBNAL flucloxacillin also represent higher free levels of active penicillin. Hence the administration of oral flucloxacillin results in serum levels of unbound drug higher than those obtained with oxacillin, cloxacillin, or dicloxacillin, thus providing higher concentrations of active antibiotic for tissue distribution (Scholtan and Schmid, 1962; Kunin, 1965 Kunin, , 1966 Verwey et al., 1966) . Similarly, after administration by intramuscular injection the serum levels of total flucloxacillin were superior to those of the other isoxazolk penicillins, and consequently the levels of unbound antibiotic are also greater for flucloxacillin than for oxacillin, cloxacillin, or dicloxacillin.
In addition to our data, experiments carried out in these laboratories by Mr. P. Acred and Mrs. P. Hunter have shown that flucloxacillin is highly active against experimental infections in mice with penicillin-resistant staphylococci. Consideration of the particular properties of flucloxacillin-namely, antibacterial activity, protein binding, and absorption in human subjects-shows that the compound is superior to oxacillin, cloxacillin, and dicloxacillin, and suggests that the clinical efficacy of flucloxacillin may be expected to compare favourably with those isoxazole penicillins at present in clinical use.
We wish to thank Dr. J. H. C. Nayler and his colleagues for preparing the penicillins used in these studies, and Mrs. Eleanor Fairclough for skilled technical assistance. Addendum D. M. BROWN, Beecham Research Laboratories, writes: Acute toxicity determinations were carried out in the mouse and in the dog. In the mouse the LD50 was established at 3-8 g./kg. orally and 2.2 g./kg. subcutaneously. In the dog, doses up to 10 g./kg. were administered orally, but all dogs vomited when they received 4-5 g./kg. and a lethal effect in the species could not be established. Long-term toxicity studies were carried out in the rat and in the dog. Doses of 200, 500, and 2,000 mg./kg. orally and 250 mg./kg. subcutaneously were administered to both species, but in the dog study the high dose had to be reduced to 1,000 mg./kg. as most of the animals vomited after receiving the drug.
Laboratory studies, which included urine and blood biochemistry and haematology, were carried out at 0, 4, 12, and 25 weeks in the rat and at 0, 6, 12, 18, and 24 weeks in the dog. At termination (25th week) necropsy was carried out on all animals and the essential organs were removed for histopathology. No adverse reactions were noted except very slight irritation at the site of the subcutaneous injections.
Teratological studies were performed in the rat and the mouse, doses of 200 and 500 mg./kg. being administered orally during days 6-15 of pregnancy in the rat and days [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] of pregnancy in the mouse. No adverse reactions were noted in the mothers or the fetuses except in the rat at the high dose, which was greatly in excess of the therapeutic dose, where there was an increased incidence of resorptions.
